BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majidpoor J, Mortezaee K. Steps in metastasis: an updated review. Med Oncol 2021;38:3. [PMID: 33394200 DOI: 10.1007/s12032-020-01447-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu S, Zhao S, Cui D, Xie J, Qian L. Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/7149686] [Reference Citation Analysis]
2 Qin YQ, Liu SY, Lv ML, Sun WL. Ambra1 in cancer: implications for clinical oncology. Apoptosis 2022. [PMID: 35994214 DOI: 10.1007/s10495-022-01762-9] [Reference Citation Analysis]
3 Lee KW, Lim S, Kim KD. The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis. Int J Mol Sci 2022;23:9365. [PMID: 36012631 DOI: 10.3390/ijms23169365] [Reference Citation Analysis]
4 George BP, Chota A, Sarbadhikary P, Abrahamse H. Fundamentals and applications of metal nanoparticle- enhanced singlet oxygen generation for improved cancer photodynamic therapy. Front Chem 2022;10:964674. [DOI: 10.3389/fchem.2022.964674] [Reference Citation Analysis]
5 Mortezaee K, Majidpoor J. Dysregulated metabolism: A friend-to-foe skewer of macrophages. International Reviews of Immunology. [DOI: 10.1080/08830185.2022.2095374] [Reference Citation Analysis]
6 Bisht S, Nigam M, Kunjwal SS, Sergey P, Mishra AP, Sharifi-rad J, Sorrenti V. Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. Stem Cells International 2022;2022:1-28. [DOI: 10.1155/2022/9653244] [Reference Citation Analysis]
7 Khunluck T, Lertsuwan K, Chutoe C, Sooksawanwit S, Inson I, Teerapornpuntakit J, Tohtong R, Charoenphandhu N. Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration. Sci Rep 2022;12:7398. [PMID: 35513484 DOI: 10.1038/s41598-022-11116-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu W, Ling C, Lee M, Cheng C, Chen R, Lin C, You R, Chen Y. Targeting Src-Hic-5 Signal Cascade for Preventing Migration of Cholangiocarcinoma Cell HuCCT1. Biomedicines 2022;10:1022. [DOI: 10.3390/biomedicines10051022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 AlGhamdi H, Dhont J, Krayem M, De Bruyn P, Engels B, Van Gestel D, Van den Begin R. The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease. Cancers (Basel) 2022;14:2046. [PMID: 35454951 DOI: 10.3390/cancers14082046] [Reference Citation Analysis]
10 Rahat MA. Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence? Front Immunol 2022;13:855978. [PMID: 35418981 DOI: 10.3389/fimmu.2022.855978] [Reference Citation Analysis]
11 Mortezaee K, Majidpoor J. CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives. Front Immunol 2022;13:864298. [DOI: 10.3389/fimmu.2022.864298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Singh R, Manna PP. Reactive oxygen species in cancer progression and its role in therapeutics. Exploration of Medicine. [DOI: 10.37349/emed.2022.00073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Du J, Wang C, Chen Y, Zhong L, Liu X, Xue L, Zhang Y, Li Y, Li X, Tang C, Su Z, Zhang C. Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.01.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Elemam NM, Malek AI, Mahmoud EE, El-huneidi W, Talaat IM. Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression. Biomedicines 2022;10:301. [DOI: 10.3390/biomedicines10020301] [Reference Citation Analysis]
15 Mortezaee K, Majidpoor J. (Im)maturity in Tumor Ecosystem. Front Oncol 2022;11:813897. [DOI: 10.3389/fonc.2021.813897] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
16 Xue K, Luo B, Li X, Deng W, Zeng C, Zuo C. Consistency evaluation of lung adenocarcinoma tissue and circulating tumor cells related gene mutation detection based on multi-site immunomagnetic beads. J Biomater Appl 2022;:8853282211065861. [PMID: 35029523 DOI: 10.1177/08853282211065861] [Reference Citation Analysis]
17 Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sci 2021;286:120057. [PMID: 34662552 DOI: 10.1016/j.lfs.2021.120057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
18 Banerjee R, Smith J, Eccles MR, Weeks RJ, Chatterjee A. Epigenetic basis and targeting of cancer metastasis. Trends in Cancer 2021. [DOI: 10.1016/j.trecan.2021.11.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Majidpoor J, Mortezaee K. Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications. Biomed Pharmacother 2021;145:112419. [PMID: 34781146 DOI: 10.1016/j.biopha.2021.112419] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
20 Margarit DH, González NS, Romanelli LM, Fendrik AJ, Scagliotti AF, Reale MV. An integrative model of cancer cell differentiation with immunotherapy. Phys Biol 2021;18. [PMID: 34633296 DOI: 10.1088/1478-3975/ac2e72] [Reference Citation Analysis]
21 Motofei IG. Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Semin Cancer Biol 2021:S1044-579X(21)00253-4. [PMID: 34695580 DOI: 10.1016/j.semcancer.2021.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sun S, Wang Y, Wang J, Bi J. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses. J Transl Med 2021;19:409. [PMID: 34579753 DOI: 10.1186/s12967-021-03061-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Najafi M, Majidpoor J, Toolee H, Mortezaee K. The current knowledge concerning solid cancer and therapy. J Biochem Mol Toxicol 2021;:e22900. [PMID: 34462987 DOI: 10.1002/jbt.22900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kondratyeva L, Chernov I, Kopantzev E, Didych D, Kuzmich A, Alekseenko I, Kostrov S, Sverdlov E. Pancreatic Lineage Specifier PDX1 Increases Adhesion and Decreases Motility of Cancer Cells. Cancers (Basel) 2021;13:4390. [PMID: 34503200 DOI: 10.3390/cancers13174390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Forma E, Bryś M. Anticancer Activity of Propolis and Its Compounds. Nutrients 2021;13:2594. [PMID: 34444754 DOI: 10.3390/nu13082594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
26 Liebs S, Eder T, Klauschen F, Schütte M, Yaspo ML, Keilholz U, Tinhofer I, Kidess-Sigal E, Braunholz D. Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities. Oncogene 2021. [PMID: 34230613 DOI: 10.1038/s41388-021-01928-w] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
27 Majidpoor J, Mortezaee K. Interleukin-2 therapy of cancer-clinical perspectives. Int Immunopharmacol 2021;98:107836. [PMID: 34218217 DOI: 10.1016/j.intimp.2021.107836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
28 Mortezaee K. Normalization in tumor ecosystem: Opportunities and challenges. Cell Biol Int 2021. [PMID: 34189798 DOI: 10.1002/cbin.11655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mortezaee K. Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives. Life Sci 2021;277:119627. [PMID: 34004256 DOI: 10.1016/j.lfs.2021.119627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
30 Majidpoor J, Mortezaee K. The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives. Clinical Immunology 2021;226:108707. [DOI: 10.1016/j.clim.2021.108707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
31 Mortezaee K. Organ tropism in solid tumor metastasis: an updated review. Future Oncology 2021;17:1943-61. [DOI: 10.2217/fon-2020-1103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
32 Xu F, Wu Q, Li L, Gong J, Huo R, Cui W. Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers. Front Pharmacol 2021;12:663776. [PMID: 33981241 DOI: 10.3389/fphar.2021.663776] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Mortezaee K. Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer. J Biochem Mol Toxicol 2021;35:e22708. [PMID: 33491255 DOI: 10.1002/jbt.22708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]